Publications by authors named "Carly Becker"

Claim this Profile
A
A BRN2:MYC transcriptional axis regulates interconversion between therapy-resistant and tumorigenic phenotypes in melanoma.
Yuntian Zhang, Marcus A Urquijo, Rebecca G Zitnay, Kayla Marks, Rachel L Belote, Carly A Becker

Cell Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing MC1R Variants in Lentigo Maligna Melanoma within the Utah Population.
Amanda Jiang, Annabelle Huntsman, Carly Becker, Bing-Jian Feng, Kayla Marks

Cancer Res Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transdermal delivery of ultradeformable cationic liposomes complexed with miR211-5p (UCL-211) stabilizes BRAFV600E+ melanocytic nevi.
Tanya Chhibber, Michael T Scherzer, Anastasia Prokofyeva, Carly Becker, Rebecca Goldstein Zitnay

J Control Release· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.
Eric A Smith, Rachel L Belote, Nelly M Cruz, Tarek E Moustafa, Carly A Becker

J Exp Clin Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with miR211-5p (UCL-211) Stabilizes BRAFV600E+ Melanocytic Nevi.
Tanya Chhibber, Michael T Scherzer, Anastasia Prokofyeva, Carly Becker, Rebecca Goldstein Zitnay

bioRxiv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soybean Oil, Linoleic Acid Source, in Lamb Diets: Intake, Digestibility, Performance, Ingestive Behaviour, and Blood Metabolites.
Victor G O Lima, Liliane O da Silva, José E de Freitas Júnior, Henry D R Alba, Willian P Silva, Carly A Becker

Animals (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.
Eric A Smith, Rachel L Belote, Nelly M Cruz, Tarek E Moustafa, Carly A Becker

bioRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis